Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

RecruitingOBSERVATIONAL
Enrollment

2,900

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2027

Conditions
Type 2 Diabetes Mellitus in RemissionMetabolic Associated Fatty Liver Disease
Interventions
PROCEDURE

Ultrasound attenuation parameter measurement, fasting blood glucose and fasting insulin determination

Eligible participants will receive ultrasound attenuation parameter with iLivTouch, fasting blood glucose and fasting insulin determination

Trial Locations (1)

Unknown

RECRUITING

Zhongda Hospital, Medical School, Southeast University, Nanjing

All Listed Sponsors
collaborator

Zhongda Hospital

OTHER

collaborator

Suzhou Municipal Hospital

OTHER

collaborator

Suzhou Fifth People's Hospital

UNKNOWN

collaborator

Xuzhou Mining Group General Hospital

UNKNOWN

collaborator

Nantong First People's Hospital

OTHER

collaborator

Changzhou Second People's Hospital

UNKNOWN

collaborator

Huaian Second People's Hospital

UNKNOWN

collaborator

Huaian Hospital

UNKNOWN

collaborator

Taizhou Jiangyan Traditional Chinese Medicine Hospital

UNKNOWN

collaborator

Yangzhou Jiangdu People's Hospital

UNKNOWN

collaborator

Huaian Xuyi County People's Hospital

UNKNOWN

lead

Wuxi Hisky Medical Technology Co Ltd

INDUSTRY